News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Method Validation by Phase of Development: An Acceptable Analytical Practice
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
Advertisement
Articles in this issue
about 21 years ago
Still Waiting for Answersabout 21 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsabout 21 years ago
November 2004about 21 years ago
In the Spotlight-November 2004about 21 years ago
Searching for a Viable Business Modelabout 21 years ago
FDA Moves To Implement New GMP PoliciesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
3
PharmTech Weekly News Roundup — Week of November 10, 2025
4
